Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TELA Bio (TELA) Change in Cash (2018 - 2025)

TELA Bio (TELA) has 8 years of Change in Cash data on record, last reported at -$5.3 million in Q3 2025.

  • For Q3 2025, Change in Cash rose 42.59% year-over-year to -$5.3 million; the TTM value through Sep 2025 reached $12.4 million, up 130.51%, while the annual FY2024 figure was $5.9 million, 19.42% up from the prior year.
  • Change in Cash reached -$5.3 million in Q3 2025 per TELA's latest filing, up from -$7.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $35.4 million in Q4 2024 and bottomed at -$12.2 million in Q4 2022.
  • Average Change in Cash over 5 years is -$2.3 million, with a median of -$8.6 million recorded in 2021.
  • Peak YoY movement for Change in Cash: soared 764.18% in 2023, then plummeted 130.3% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$9.7 million in 2021, then dropped by 25.78% to -$12.2 million in 2022, then grew by 8.18% to -$11.2 million in 2023, then surged by 415.57% to $35.4 million in 2024, then plummeted by 114.93% to -$5.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were -$5.3 million in Q3 2025, -$7.9 million in Q2 2025, and -$9.8 million in Q1 2025.